TREATMENT OF DIABETES USING ANTIBODIES TO IL-23, IL-23 RECEPTOR AND IL-17

Patent №

US 7,820,168

Granted

2010-10-26

Filed 2005

Owner

SCHERING CORPORATION

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11305748

The instant specification provides methods of treatment for inflammatory and autoimmune disorders of the metabolic system. The instant specification also provides methods of diagnosis.

PlanningC07K 16/244A61K 31/52A61K 31/573A61K 38/13A61K 38/1793A61K 45/06A61P 3/08A61P 3/10+7 more

AI classification

Planning0.81
Natural language0.01
Evolutionary computation0.00
AI hardware0.00
Vision0.00
Machine learning0.00
Knowledge representation0.00
Speech0.00

Ownership

SCHERING CORPORATION

assignment · 169890398

Assignors

CUA, DANIEL J., KASTELEIN, ROBERT A.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC